A Phase 1 Trial of Indoximod in Combination With Idarubicin and Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Indoximod (Primary) ; Cytarabine; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors NewLink Genetics Corporation
- 03 Jun 2020 Status changed from recruiting to completed.
- 17 Apr 2019 Planned End Date changed from 1 Jul 2018 to 1 May 2020.
- 17 Apr 2019 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.